Special Issue "Research in Innate and Adaptive Immunity"
Deadline for manuscript submissions: 31 December 2023 | Viewed by 2604
Interests: immunonutrition; (trained) innate immunity; antigen presenting cells; hepatocarcinoma
Interests: polyphenols; in vitro; in vivo; pharmacology; eicosanoids; inflammation; cardiovascular; health; bioactive molecules
Special Issues, Collections and Topics in MDPI journals
Special Issue in Biomedicines: 10th Anniversary of Biomedicines—Intestinal Homeostasis and the Crosstalk within the Gut-Liver Axis
Special Issue in International Journal of Molecular Sciences: Dietary Bioactive Compounds and Breast Cancer II
Special Issue in Current Issues in Molecular Biology: Dietary Bioactive Compounds and Breast Cancer
The intricate immune signals between both innate and adaptive branches of the immune system not only represent our first line of defense but also allow us to normally develop during ontogeny. These interactions take place sequentially to establish adequate metabolic and microbial commensal response(s), offering protection to exogenous biological entities and to an exaggerated inflammation. Complex cellular and humoral networks of adaptive immune cells and metabolic products are well known. However, fundamental questions remain unanswered about the interconnexion between innate and adaptive immune response(s) to immunoevasion. These will improve our knowledge on immunometabolic diseases, cancer, virus clearance, and recovery of immunocompetence. Identification and development of those with a concerted perspective will overcome the usually fragmented and compartmentalized approach to addressing the underlying immune alterations. Integrating both components in the context of its relationship to exposures (i.e., diet, environment, microbiota) and the host’s intrinsic and modifiable factors and disease outcomes will contribute toward vaccine and immunotherapeutic design and evaluation.
Dr. Jose Moisés Laparra
Dr. Juan Antonio Giménez-Bastida
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- innate immunity
- adaptive immunity
- trained immunity